Circadian Regulation of Retinal Pigment Epithelium Function.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 26 01 2022
revised: 16 02 2022
accepted: 21 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

The retinal pigment epithelium (RPE) is a single layer of cells located between the choriocapillaris vessels and the light-sensitive photoreceptors in the outer retina. The RPE performs physiological processes necessary for the maintenance and support of photoreceptors and visual function. Among the many functions performed by the RPE, the timing of the peak in phagocytic activity by the RPE of the photoreceptor outer segments that occurs 1-2 h. after the onset of light has captured the interest of many investigators and has thus been intensively studied. Several studies have shown that this burst in phagocytic activity by the RPE is under circadian control and is present in nocturnal and diurnal species and rod and cone photoreceptors. Previous investigations have demonstrated that a functional circadian clock exists within multiple retinal cell types and RPE cells. However, the anatomical location of the circadian controlling this activity is not clear. Experimental evidence indicates that the circadian clock, melatonin, dopamine, and integrin signaling play a key role in controlling this rhythm. A series of very recent studies report that the circadian clock in the RPE controls the daily peak in phagocytic activity. However, the loss of the burst in phagocytic activity after light onset does not result in photoreceptor or RPE deterioration during aging. In the current review, we summarized the current knowledge on the mechanism controlling this phenomenon and the physiological role of this peak.

Identifiants

pubmed: 35269840
pii: ijms23052699
doi: 10.3390/ijms23052699
pmc: PMC8910459
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NEI NIH HHS
ID : R01EY026291
Pays : United States
Organisme : NEI NIH HHS
ID : R21EY031821
Pays : United States
Organisme : NIGMS NIH HHS
ID : SC1GM135112
Pays : United States

Références

Science. 1996 Apr 19;272(5260):419-21
pubmed: 8602533
J Neurosci. 2003 Apr 1;23(7):3085-93
pubmed: 12684495
Sci Rep. 2017 Jul 11;7(1):5103
pubmed: 28698578
PLoS Biol. 2008 Oct 14;6(10):e249
pubmed: 18959477
Invest Ophthalmol Vis Sci. 1980 Nov;19(11):1268-73
pubmed: 7429763
Invest Ophthalmol Vis Sci. 1979 Oct;18(10):1019-24
pubmed: 478775
J Biol Chem. 2003 Nov 14;278(46):45101-8
pubmed: 12954639
Science. 1976 Dec 3;194(4269):1071-4
pubmed: 982063
Neuroreport. 2002 Jun 12;13(8):1013-6
pubmed: 12060798
Exp Eye Res. 2017 Dec;165:90-95
pubmed: 28941766
Nat Protoc. 2016 Jul;11(7):1206-18
pubmed: 27281648
Physiology (Bethesda). 2010 Feb;25(1):8-15
pubmed: 20134024
J Neurophysiol. 2003 Dec;90(6):3854-63
pubmed: 12930817
Eur J Ophthalmol. 2012 Jul-Aug;22(4):647-53
pubmed: 22180149
J Cell Sci. 1993 Jan;104 ( Pt 1):37-49
pubmed: 8383696
Genes Dev. 2006 Jul 15;20(14):1868-73
pubmed: 16847346
Vis Neurosci. 1999 Sep-Oct;16(5):909-18
pubmed: 10580726
Invest Ophthalmol Vis Sci. 1985 Nov;26(11):1599-609
pubmed: 4055292
Int Rev Cytol. 2000;196:245-313
pubmed: 10730217
FASEB J. 2016 Nov;30(11):3690-3701
pubmed: 27440795
J Biol Rhythms. 2018 Aug;33(4):441-445
pubmed: 29940798
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11607-12
pubmed: 10500224
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4856-4870
pubmed: 30347082
Br J Ophthalmol. 2008 Oct;92(10):1419-23
pubmed: 18815424
Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13093-8
pubmed: 26392540
Vision Res. 1980;20(12):1173-7
pubmed: 7269273
FASEB J. 2013 Nov;27(11):4585-95
pubmed: 23913857
Mol Biol Cell. 2009 Sep;20(17):3896-904
pubmed: 19587120
Mol Vis. 2010 Dec 07;16:2605-11
pubmed: 21151601
J Biol Chem. 1997 Mar 14;272(11):6979-85
pubmed: 9054387
Neurobiol Dis. 2000 Dec;7(6 Pt B):586-99
pubmed: 11114258
J Biol Chem. 2004 Jun 4;279(23):24064-72
pubmed: 15150258
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):3109-18
pubmed: 16799057
Invest Ophthalmol Vis Sci. 2004 May;45(5):1456-63
pubmed: 15111602
PLoS One. 2017 Sep 21;12(9):e0184790
pubmed: 28934261
Br J Ophthalmol. 2006 Jun;90(6):718-23
pubmed: 16714263
J Biol Chem. 2017 Aug 4;292(31):12895-12905
pubmed: 28615447
FASEB J. 2021 Jul;35(7):e21722
pubmed: 34160105
Brain Res. 1986 Mar 26;369(1-2):356-60
pubmed: 3697752
Science. 1978 Nov 24;202(4370):901-2
pubmed: 30997
Exp Eye Res. 1996 Feb;62(2):155-69
pubmed: 8698076
Neurosci Lett. 2008 Nov 28;446(1):40-4
pubmed: 18809466
Exp Eye Res. 2014 Sep;126:77-84
pubmed: 24485945
J Ophthalmol. 2014;2014:801787
pubmed: 25177495
Brain Res. 1993 Mar 12;605(2):256-64
pubmed: 8481775
BMC Biol. 2015 Jun 23;13:43
pubmed: 26099272
Proc Natl Acad Sci U S A. 2006 Apr 18;103(16):6386-91
pubmed: 16606840
J Neurosci. 1997 Jan 15;17(2):667-75
pubmed: 8987789
Science. 1993 Apr 9;260(5105):238-41
pubmed: 8097062
Hum Mol Genet. 2000 Mar 1;9(4):645-51
pubmed: 10699188
Front Endocrinol (Lausanne). 2018 Mar 19;9:108
pubmed: 29615980
J Tissue Eng. 2016 Jul 12;7:2041731416650838
pubmed: 27493715
Sci Rep. 2019 Aug 13;9(1):11790
pubmed: 31409842
Exp Eye Res. 2020 Apr;193:107985
pubmed: 32092287
Sci Rep. 2021 May 17;11(1):10449
pubmed: 34001977
Cell Rep. 2017 Oct 17;21(3):692-706
pubmed: 29045837
Exp Eye Res. 2020 Apr;193:107988
pubmed: 32105725
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12005-10
pubmed: 17620600
FASEB J. 2015 Apr;29(4):1493-504
pubmed: 25573753
Science. 1983 Mar 18;219(4590):1341-3
pubmed: 6828862
Biochem Biophys Res Commun. 2006 Nov 10;350(1):169-73
pubmed: 16996031
Methods Mol Biol. 2013;935:285-95
pubmed: 23150376
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):94-104
pubmed: 26780313
Nat Neurosci. 1998 Dec;1(8):693-700
pubmed: 10196585
Sci Rep. 2017 Mar 09;7:44175
pubmed: 28276525
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4753-8
pubmed: 26207312
Biochem Biophys Res Commun. 2003 Jun 6;305(3):494-501
pubmed: 12763020
FEBS Lett. 2000 Jan 7;465(1):79-82
pubmed: 10620710
Prog Retin Eye Res. 2020 Feb 24;:100846
pubmed: 32105772
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5339-46
pubmed: 14963227
Exp Eye Res. 2014 Sep;126:46-50
pubmed: 24060345
Prog Brain Res. 2001;131:617-27
pubmed: 11420975
FASEB J. 2007 Dec;21(14):3866-71
pubmed: 17621597
Cell. 2007 Aug 24;130(4):730-741
pubmed: 17719549
Mol Vis. 2010 Mar 09;16:369-77
pubmed: 20300561
Nature. 1999 Apr 22;398(6729):723-8
pubmed: 10227296
Proc Natl Acad Sci U S A. 2003 May 27;100(11):6481-6
pubmed: 12743369
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8145-8
pubmed: 22566632
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):15043-8
pubmed: 19706469
Eur J Neurosci. 2004 Feb;19(4):907-15
pubmed: 15009138
Eur J Neurosci. 2013 Apr;37(7):1048-60
pubmed: 23351077
Nat Protoc. 2009;4(5):662-73
pubmed: 19373231
Mol Cell Neurosci. 2006 Sep;33(1):96-108
pubmed: 16901715
Invest Ophthalmol Vis Sci. 2020 May 11;61(5):10
pubmed: 32396631
J Cell Sci Suppl. 1993;17:189-95
pubmed: 8144697
Neurosci Lett. 1986 Dec 12;72(2):221-6
pubmed: 3492691
J Exp Med. 2004 Dec 20;200(12):1539-45
pubmed: 15596525
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13099-13104
pubmed: 30498030
Mol Vis. 2010 Dec 28;16:2873-81
pubmed: 21203345

Auteurs

Kenkichi Baba (K)

Department of Pharmacology & Toxicology and Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA.

Varunika Goyal (V)

Department of Pharmacology & Toxicology and Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA.

Gianluca Tosini (G)

Department of Pharmacology & Toxicology and Neuroscience Institute, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA.

Articles similaires

Humans Circadian Rhythm Adult Aged Aging
Humans Retinal Pigment Epithelium Retinal Degeneration Animals Tissue Scaffolds
Microglia Animals Neurons Humans Cell Death

Classifications MeSH